GLP3, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: A randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
Cordycepin-melittin nanoconjugate intensifies wound healing efficacy in diabetic rats
Priority Applications (3) Applications Claiming Priority (2) Publications (1) Family ID=67805224 Family Applications (1) Country Status (4) Cited By (2) Citations (1) Family Cites Families (8) 2019 2019-02-27 US US16/976,304 patent/US12151031B2/en active Active 2019-02-27 WO PCT/IN2019/050161 patent/WO2019167070A1/en not_active Ceased 2019-02-27 EP EP19760988.6A patent/EP3758731A4/en active Pending 2019-02-27 CA CA3092487A patent/CA3092487A1/en active Pending
Your routine does the work
It may promote the growth of new blood vessels, enhance blood flow, and improve cardiac function, potentially benefiting individuals with cardiovascular conditions
Can pharmacies provide private vitamin B12 injections